Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Tolerability of Multiple Ascending Doses of LY2140023 in Subjects With Schizophrenia

NCT01354353 is registered in ClinicalTrials.gov with Denovo Biopharma LLC as lead sponsor.

NCT NCT01354353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01354353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Tolerability of Multiple Ascending Doses of LY2140023 in Subjects With Schizophrenia
Lead sponsor
Denovo Biopharma LLC
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2011
Completion date
March 31, 2012
Enrollment
75 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia